Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
1,360,676
-
Shares change
-
-140,269
-
Total reported value, excl. options
-
$196,592,354
-
Value change
-
-$20,154,851
-
Number of buys
-
26
-
Number of sells
-
-50
-
Price
-
$144.4
Significant Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q2 2016
99 filings reported holding IHE - ISHARES TR - U.S. PHARMA ETF as of Q2 2016.
ISHARES TR - U.S. PHARMA ETF (IHE) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,360,676 shares
.
Largest 10 shareholders include MORGAN STANLEY (214,743 shares), BANK OF AMERICA CORP /DE/ (129,192 shares), ARS Wealth Advisors, LLC (103,172 shares), GOLDMAN SACHS GROUP INC (100,630 shares), BROWN ADVISORY INC (79,158 shares), SPINNAKER TRUST (70,678 shares), SPC Financial, Inc. (62,908 shares), ROYAL BANK OF CANADA (50,906 shares), WELLS FARGO & COMPANY/MN (44,956 shares), and EFG Asset Management (Americas) Corp. (44,564 shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.